Dr. Nabil Rizk, chief of thoracic surgery at Hackensack University Medical Center, explains that segmentectomy is “just a little bit more of a refined way of treating cancers.” As surgical treatments ...

Phase IB Study of Selinexor, a First-in-Class Inhibitor of Nuclear Export, in Patients With Advanced Refractory Bone or Soft Tissue Sarcoma In this study, we used the large Surveillance, Epidemiology, ...

The research team of Prof. Hyun Koo Kim of the Department of Thoracic and Cardiovascular Surgery, Korea University's Guro Hospital, developed the "precise and safe pulmonary segmentectomy enabled by ...

Multicenter phase II study of concurrent high-dose (72Gy) three-dimensional conformal radiotherapy (3D-CRT) without elective nodal irradiation with chemotherapy using cisplatin and vinorelbine for ...

New research presented at the 2025 Society of Thoracic Surgeons (STS) Annual Meeting reveals that anatomic lung resections, such as lobectomy and segmentectomy, are associated with improved long-term ...

November 5, 2010 (Vancouver, British Columbia) — In patients with clinical stage I nonsmall-cell lung cancer (NSCLC), anatomic segmentectomy has recurrence and survival rates similar to lobectomy, but ...

CHICAGO — Claudia Donohue was on the operating table first thing in the morning. It wasn’t where she wanted to end up when she first learned she had lung cancer. When she saw the constellation of ...

LOS ANGELES—January 25, 2025 New research presented at the 2025 Society of Thoracic Surgeons (STS) Annual Meeting reveals that anatomic lung resections, such as lobectomy and segmentectomy, are ...

Lung cancer is a common and serious type of cancer that is considered to be the most common type of cancer to affect people worldwide. In fact, at the end of 2018, about 2.1 million new cases of lung ...

LOS ANGELES -- Surgeries to remove small tumors in stage IA non-small cell lung cancer (NSCLC) were associated with varying odds of long-term survival depending on the amount of lung removed, based on ...

Surgery may be underused in patients with limited-stage small cell lung cancer (SCLC), suggest the investigators of a recent study. 1 But when to operate? And what is the optimal surgical approach?